PubRank

Shulin Li

Author PubWeight™ 40.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell Mol Life Sci 2011 3.80
2 Interleukin-30: a novel antiinflammatory cytokine candidate for prevention and treatment of inflammatory cytokine-induced liver injury. Hepatology 2012 1.62
3 A quality control pathway that down-regulates aberrant T-cell receptor (TCR) transcripts by a mechanism requiring UPF2 and translation. J Biol Chem 2002 1.43
4 Alternatively spliced TCR mRNA induced by disruption of reading frame. Science 2002 1.34
5 Universal marker and detection tool for human sarcoma circulating tumor cells. Cancer Res 2014 1.34
6 Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2012 1.17
7 Sonoporation delivery of interleukin-27 gene therapy efficiently reduces prostate tumor cell growth in vivo. Hum Gene Ther 2011 1.17
8 Technologies for deriving primary tumor cells for use in personalized cancer therapy. Trends Biotechnol 2013 1.15
9 Discovery of a linear peptide for improving tumor targeting of gene products and treatment of distal tumors by IL-12 gene therapy. Mol Ther 2011 1.14
10 Regression of high-grade malignancy in mice by bleomycin and interleukin-12 electrochemogenetherapy. Clin Cancer Res 2006 1.07
11 IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells. Eur J Immunol 2013 1.06
12 IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors. J Immunol 2010 1.06
13 IL-30 (IL27p28) attenuates liver fibrosis through inducing NKG2D-rae1 interaction between NKT and activated hepatic stellate cells in mice. Hepatology 2014 0.97
14 The role of the liver in sepsis. Int Rev Immunol 2014 0.95
15 Intratumoral bleomycin and IL-12 electrochemogenetherapy for treating head and neck tumors in dogs. Methods Mol Biol 2008 0.95
16 Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance. Cancer Res 2009 0.93
17 Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 2002 0.91
18 Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. Clin Cancer Res 2007 0.91
19 Stat1 deficiency in the host enhances interleukin-12-mediated tumor regression. Cancer Res 2006 0.91
20 Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles. Nanoscale 2013 0.89
21 Electroporation advances in large animals. Curr Gene Ther 2009 0.87
22 Function and molecular mechanism of tumor-targeted peptides for delivering therapeutic genes and chemical drugs. Mini Rev Med Chem 2006 0.85
23 Small molecule ErbB inhibitors decrease proliferative signaling and promote apoptosis in philadelphia chromosome-positive acute lymphoblastic leukemia. PLoS One 2013 0.85
24 Administering plasmid DNA encoding tumor vessel-anchored IFN-alpha for localizing gene product within or into tumors. Mol Ther 2008 0.85
25 Primary ovarian trabecular carcinoid tumor: a case report and literature review. Arch Gynecol Obstet 2010 0.82
26 Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells. Biol Proced Online 2012 0.81
27 Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30. J Immunol 2012 0.81
28 Safe and effective treatment of spontaneous neoplasms with interleukin 12 electro-chemo-gene therapy. J Cell Mol Med 2015 0.80
29 The mechanism of exogenous B7.1-enhanced IL-12-mediated complete regression of tumors by a single electroporation delivery. Int J Cancer 2006 0.80
30 WSX1 expression in tumors induces immune tolerance via suppression of effector immune cells. PLoS One 2011 0.80
31 Treatment of SCCVII tumors with systemic chemotherapy and Interleukin-12 gene therapy combination. Methods Mol Biol 2008 0.79
32 Intraosseous inoculation of tumor cells into bone marrow promotes distant metastatic tumor development: A novel tool for mechanistic and therapeutic studies. Cancer Lett 2012 0.79
33 TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome. J Clin Invest 2016 0.78
34 Herceptin conjugates linked by EDC boost direct tumor cell death via programmed tumor cell necrosis. PLoS One 2011 0.78
35 Electroporation formulation for cell therapy. Methods Mol Biol 2014 0.77
36 Managing local swelling following intratumoral electro-chemo-gene therapy. Methods Mol Biol 2014 0.77
37 Natriuretic peptide receptors in the human endolymphatic sac. Arch Otolaryngol Head Neck Surg 2002 0.77
38 Electroporation gene therapy. Preface. Methods Mol Biol 2008 0.77
39 Atrial natriuretic peptide receptor upregulation in the rat inner ear. Ann Otol Rhinol Laryngol 2002 0.77
40 Targeted delivery of Doxorubicin by folic acid-decorated dual functional nanocarrier. Mol Pharm 2014 0.77
41 The impact of non-electrical factors on electrical gene transfer. Methods Mol Biol 2014 0.76
42 Systemic IL-12 gene therapy for treating malignancy via intramuscular electroporation. Methods Mol Biol 2008 0.75
43 [Influence of incubation time on metabolites in mycelia of Paecilomyces militaris]. Wei Sheng Wu Xue Bao 2012 0.75
44 [Identification of spore germination and virulence related biomarkers from Beauveria bassiana using an LC-MS-based metabolomic technique]. Wei Sheng Wu Xue Bao 2014 0.75